Monday - April 27, 2026
Tipoffs for Maine (New England) Newsletter for Tuesday June 03, 2025 ( 9 items )  

Announcing the 2025 Pulitzer Center Reporting Fellows
WASHINGTON, June 3 [Category: Media] -- Pulitzer Center, an organization that say it combines journalism and engagement, posted the following news: * * * Announcing the 2025 Pulitzer Center Reporting Fellows By Jazmyn Gray, Pulitzer Center Staff The Pulitzer Center is excited to announce its 2025 cohort of 49 Reporting Fellows. Their projects address some of the most critical and underreported stories in today's world, including migration, global health, and climate solutions. "This year'  more

Camizestrant Reduced the Risk of Disease Progression or Death by 56% in Patients With Advanced HR-Positive Breast Cancer With an Emergent ESR1 Tumor Mutation in SERENA-6 Phase III Trial
WILMINGTON, Delaware, June 3 -- AstraZeneca, a biopharmaceutical company, issued the following news release: * * * Camizestrant reduced the risk of disease progression or death by 56% in patients with advanced HR-positive breast cancer with an emergent ESR1 tumor mutation in SERENA-6 Phase III trial First pivotal trial to demonstrate clinical value of monitoring circulating tumor DNA to detect and treat emerging resistance in 1st-line therapy ahead of disease progression in breast cancer Fir  more

Drug Combination Increases Overall Survival in Patients With PIK3CA-Mutated Advanced Breast Cancer
BOSTON, Massachusetts, June 3 -- Mass General Brigham issued the following news release: * * * New Drug Combination Increases Overall Survival in Patients with PIK3CA-Mutated Advanced Breast Cancer Mutations in the PIK3CA gene are a key driver of breast cancer and are present in 35-40% of hormone receptor-positive breast cancers. A recently completed phase 3 clinical trial, conducted by researchers at Mass General Brigham and collaborators, shows that combining inavolisib with palbociclib and  more

IMFINZI (durvalumab) Regimen Reduced Risk of Progression, Recurrence or Death by 29% in Early-Stage Gastric Cancer vs. Chemotherapy Alone in MATTERHORN Phase III Trial
WILMINGTON, Delaware, June 3 -- AstraZeneca, a biopharmaceutical company, issued the following news release: * * * IMFINZI (durvalumab) regimen reduced risk of progression, recurrence or death by 29% in early-stage gastric cancer vs. chemotherapy alone in MATTERHORN Phase III trial Two-thirds (67.4%) of patients treated with IMFINZI-based perioperative regimen remained event-free at two years First and only immunotherapy to demonstrate statistically significant event-free survival in a globa  more

NATIONAL GEOGRAPHIC PARTNERS: BIGGER BOAT, BIGGER LEGACY!
WASHINGTON, May 30 -- National Geographic Partners, a joint venture between Walt Disney and National Geographic Society, issued the following news release: * * * BIGGER BOAT, BIGGER LEGACY! NATIONAL GEOGRAPHIC CELEBRATES THE 50TH ANNIVERSARY OF BLOCKBUSTER FILM JAWS WITH THE ONLY AUTHORIZED DOCUMENTARY, JAWS @ 50: THE DEFINITIVE INSIDE STORY, FEATURING EXCLUSIVE NEW INTERVIEWS WITH DIRECTOR STEVEN SPIELBERG Produced in Partnership With Spielberg's Amblin Documentaries, Nedland Films and Wend  more

New England For-Hire Groundfish Fleet Partners with NOAA Fisheries to Improve Cod Data
WASHINGTON, June 2 -- The National Oceanic and Atmospheric Administration issued the following news: * * * New England For-Hire Groundfish Fleet Partners with NOAA Fisheries to Improve Cod Data * Atlantic cod is a classic New England fish, found everywhere from roadside fish-and-chip stands to the Massachusetts State House. Under the Magnuson-Stevens Act, NOAA Fisheries fosters the long-term biological and economic sustainability of marine fisheries, including rebuilding overfished stocks. C  more

University of New England Earns National Recognition for Student Success and Outcomes
BIDDEFORD, Maine, June 3 -- The University of New England issued the following news: * * * University of New England earns national recognition for student success and outcomes The University of New England has been named a 2025-26 College of Distinction, joining a select group of institutions recognized for their commitment to delivering an exceptional undergraduate college experience. The distinction, awarded by the national Colleges of Distinction program, is based on four pillars: engaged  more

Welch Joins Planned Parenthood of Northern New England for Roundtable on Republicans' Attacks on Abortion and Reproductive Care
WASHINGTON, June 2 -- Sen. Peter Welch, D-Vermont, issued the following news release: * * * Welch Joins Planned Parenthood of Northern New England for Roundtable on Republicans' Attacks on Abortion and Reproductive Care * WASHINGTON, D.C. -- Today, U.S. Senator Peter Welch (D-Vt.) joined Planned Parenthood of Northern New England (PPNNE) for a virtual roundtable highlighting the harmful consequences of Republicans' reconciliation bill for patients in Vermont. The Republican budget will drama  more

Your Recreational Catch Information Helps Assess the Health of our Fisheries
WASHINGTON, June 2 -- The National Oceanic and Atmospheric Administration issued the following news: * * * Your Recreational Catch Information Helps Assess the Health of our Fisheries * Recreational fishing is one of the great American pastimes--fostering connections to nature, family, and friends. It's also a national economic driver, supporting 700,000 jobs and generating $138 billion in sales. Experts at NOAA Fisheries' regional science centers, in consultation with states and regional   more